Tirzepatide：

5mg/10mg/15mg/vial*10vial/box.

Tirzepatide is an antidiabetic drug used to treat type 2 diabetes and for weight loss.

Blood Sugar Control:
Tirzepatide is a long-acting GIP analog that activates GLP-1 and GIP receptors, Enhances the secretion of insulin, thereby improving glycemic control.

Weight Loss:

Tirzepatide can also be used as an adjunct to a low-calorie diet and increased physical activity, Mimics Natural Hormones to promote satiety. for long-term weight management.
The FDA approved Tirzepatide for weight loss in 2023.

USAGE: 

Once-a-Week Injection: 
It is a once-a-week subcutaneous injectable medication with incremental dose increases.

Start at the 2.5 mg dose once weekly; 
after 4 weeks on the 2.5 mg dose, increase to the 5 mg dose once weekly.
Administer once weekly, any time of day, with or without meals.

NOTE: 
This product for Research use only.
We ship all over the world by dedicated line. 
You are advised to consult your medical consultations before use of the product.